tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hepatopulmonary Syndrome D020065 1 associated lipids
Herpes Labialis D006560 1 associated lipids
End Stage Liver Disease D058625 1 associated lipids
Nocturnal Myoclonus Syndrome D020189 1 associated lipids
Uveomeningoencephalitic Syndrome D014607 1 associated lipids
Myelitis D009187 1 associated lipids
IgG Deficiency D017099 1 associated lipids
Deltaretrovirus Infections D006800 1 associated lipids
Dendritic Cell Sarcoma, Interdigitating D054739 1 associated lipids
Polymyositis D017285 1 associated lipids
Scorpion Stings D065008 1 associated lipids
Rotavirus Infections D012400 1 associated lipids
Netherton Syndrome D056770 1 associated lipids
Pseudohypoaldosteronism D011546 1 associated lipids
Arm Injuries D001134 1 associated lipids
Intussusception D007443 1 associated lipids
Thrombotic Microangiopathies D057049 1 associated lipids
Autoimmune Diseases of the Nervous System D020274 1 associated lipids
Lupus Erythematosus, Discoid D008179 1 associated lipids
Lymphocytic Choriomeningitis D008216 1 associated lipids
Erythroplasia D004919 1 associated lipids
Hepatic Veno-Occlusive Disease D006504 1 associated lipids
West Nile Fever D014901 1 associated lipids
Hypoalbuminemia D034141 1 associated lipids
AIDS-Associated Nephropathy D016263 1 associated lipids
Oral Ulcer D019226 1 associated lipids
Epidermolysis Bullosa Dystrophica D016108 1 associated lipids
Primary Graft Dysfunction D055031 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Epididymitis D004823 1 associated lipids
Pruritus Vulvae D011539 1 associated lipids
Central Serous Chorioretinopathy D056833 1 associated lipids
Feline Acquired Immunodeficiency Syndrome D016181 1 associated lipids
Budd-Chiari Syndrome D006502 1 associated lipids
Porokeratosis D017499 1 associated lipids
Lentigo D007911 1 associated lipids
Mutism D009155 1 associated lipids
Amyloid Neuropathies D017772 1 associated lipids
Cervical Intraepithelial Neoplasia D018290 1 associated lipids
Migraine with Aura D020325 1 associated lipids
Denys-Drash Syndrome D030321 1 associated lipids
Akinetic Mutism D000405 1 associated lipids
Sleep Apnea, Central D020182 1 associated lipids
Orchitis D009920 1 associated lipids
Phyllodes Tumor D003557 1 associated lipids
Meningitis, Fungal D016921 1 associated lipids
Malocclusion, Angle Class II D008312 1 associated lipids
Flaviviridae Infections D018178 1 associated lipids
Idiopathic Interstitial Pneumonias D054988 1 associated lipids
Dysuria D053159 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Shapiro R The development of tacrolimus in renal transplantation. 2001 Nov-Dec Transplant. Proc. pmid:11750356
Keshavamurthy M et al. Single-center study utilizing C(2) level as monitoring tool in de novo renal transplant recipients treated with Neoral. 2001 Nov-Dec Transplant. Proc. pmid:11750338
Chen JC and Ma P Mechanism of FK506-induced renal hypoperfusion and its reversion in rats. 2001 Acta Pharmacol. Sin. pmid:11749797
Kihara M et al. A small dose of the immunosuppressive agent FK506 (tacrolimus) protects peripheral nerve from ischemic fiber degeneration. 2001 Muscle Nerve pmid:11745968
Chan SA and Smith C Physiological stimuli evoke two forms of endocytosis in bovine chromaffin cells. 2001 J. Physiol. (Lond.) pmid:11744761
Keogh AM et al. A randomized trial of tacrolimus (FK506) versus total lymphoid irradiation for the control of repetitive rejection after cardiac transplantation. 2001 J. Heart Lung Transplant. pmid:11744418
Avramut M et al. The immunosuppressant drug FK506 is a potent trophic agent for human fetal neurons. 2001 Brain Res. Dev. Brain Res. pmid:11744119
Nagano Y et al. Lack of binding observed between human alpha-synuclein and Bcl-2 protein family. 2001 Neurosci. Lett. pmid:11742726
Boukriche Y et al. Severe axonal polyneuropathy after a FK506 overdosage in a lung transplant recipient. 2001 Transplantation pmid:11740402
Benito N et al. Alternariosis after liver transplantation. 2001 Transplantation pmid:11740399
Yang CW et al. Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. 2001 Transplantation pmid:11740384
Hodgson T et al. Topical tacrolimus and Crohn disease. 2001 J. Pediatr. Gastroenterol. Nutr. pmid:11740245
Khouri IF et al. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. 2001 Blood pmid:11739162
Vanrenterghem YF Tailoring immunosuppressive therapy for renal transplant recipients. 2001 Pediatr Transplant pmid:11737774
Flynn JT et al. Indications, results, and complications of tacrolimus conversion in pediatric renal transplantation. 2001 Pediatr Transplant pmid:11737770
Sano N et al. High trough levels of oral FK506 induced by loss of small intestine. 2001 Pediatr Transplant pmid:11737769
Klein AW Commentary on topical tacrolimus in the treatment of bovine collagen hypersensitivity. 2001 Dermatol Surg pmid:11737142
Sugiura H et al. An open study of a lotion formulation to improve tolerance of tacrolimus in facial atopic dermatitis. 2001 Br. J. Dermatol. pmid:11736904
Bigby M A thorough systematic review of treatments for atopic eczema. 2001 Arch Dermatol pmid:11735714
Dubowchik GM et al. 2-Aryl-2,2-difluoroacetamide FKBP12 ligands: synthesis and X-ray structural studies. 2001 Org. Lett. pmid:11735566
Bartynski WS et al. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. 2001 Nov-Dec AJNR Am J Neuroradiol pmid:11733324
Mayer K et al. [FK 506 ointment 0.1 % - A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients]. 2001 Klin Monbl Augenheilkd pmid:11731901
Pilmore HL et al. Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature. 2001 Transplantation pmid:11726837
Washburn K et al. Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil. 2001 Transplantation pmid:11726831
Maes BD et al. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. 2001 Transplantation pmid:11726827
Bruce DS et al. Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients. 2001 Transplantation pmid:11726823
Krentz AJ Posttransplantation Diabetes Mellitus in FK-506-Treated Renal Transplant Recipients: Analysis of Incidence and Risk Factors. Transplantation 2001; 72: 1655. 2001 Transplantation pmid:11726815
Cífková R and Hallen H Cyclosporin-induced hypertension. 2001 J. Hypertens. pmid:11725176
Granlund H et al. Treatment of lichenified atopic eczema with tacrolimus ointment. 2001 Aug-Sep Acta Derm. Venereol. pmid:11720192
Nemoto H et al. FK506 suppressed the inflammatory change of EAM in SJL/J mice. 2001 J. Neurol. Sci. pmid:11718743
Alemdar AY et al. Liposomal tacrolimus administered systemically and within the donor cell suspension improves xenograft survival in hemiparkinsonian rats. 2001 Exp. Neurol. pmid:11716565
Almawi WY et al. Inhibition of cytokine production and cytokine-stimulated T-cell activation by FK506 (tacrolimus)1. 2001 Cell Transplant pmid:11714196
Sakuma S et al. FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis. 2001 Inflamm. Res. pmid:11713905
Milting H et al. FK506 does not affect cardiac contractility and adrenergic response in vitro. 2001 Eur. J. Pharmacol. pmid:11711047
Chu FC et al. Oral health status, oral microflora, and non-surgical periodontal treatment of renal transplant patients receiving cyclosporin A and FK506. 2000 Ann R Australas Coll Dent Surg pmid:11709958
Hernández G et al. Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient. 2001 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:11709689
Lash LH et al. Apoptosis, necrosis, and cell proliferation induced by S-(1,2-dichlorovinyl)-L-cysteine in primary cultures of human proximal tubular cells. 2001 Toxicol. Appl. Pharmacol. pmid:11708895
Waldman WJ et al. Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide. 2001 Transplantation pmid:11707749
Trancassini M et al. Microbiologic investigation on patients with cystic fibrosis subjected to bilateral lung transplantation. 2001 Transplantation pmid:11707748
Yamada T et al. Role of T cells in development of chronic pancreatitis in male Wistar Bonn/Kobori rats: effects of tacrolimus. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11705744
Takahata M et al. Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus. 2001 Bone Marrow Transplant. pmid:11704797
Okano A et al. Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation. 2001 Bone Marrow Transplant. pmid:11704796
Scammell JG et al. Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. 2001 Gen. Comp. Endocrinol. pmid:11703081
Tsukamoto T et al. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats. 2001 Psychopharmacology (Berl.) pmid:11702083
Fukatsu S et al. Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation. 2001 Eur. J. Clin. Pharmacol. pmid:11699612
Kogan-Liberman D et al. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. 2001 J. Pediatr. Gastroenterol. Nutr. pmid:11698761
Amberg GC et al. Regulation of A-type potassium channels in murine colonic myocytes by phosphatase activity. 2001 Am. J. Physiol., Cell Physiol. pmid:11698261
Miyauchi T et al. Experimental study of combined treatment with tacrolimus and donor splenocytes via the portal vein in small bowel transplantation. 2001 J. Med. Invest. pmid:11694955
Cristillo AD and Bierer BE Identification of novel targets of immunosuppressive agents by cDNA-based microarray analysis. 2002 J. Biol. Chem. pmid:11694517
Fukada J et al. Long-term survival of rat cardiac allografts by intrathymic plus portal venous injections of donor bone marrow cells and short-term tacrolimus immunosuppression. 2001 Transpl. Int. pmid:11692215
Trautmann A et al. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. 2001 J. Allergy Clin. Immunol. pmid:11692113
Tucker CL and Fields S A yeast sensor of ligand binding. 2001 Nat. Biotechnol. pmid:11689849
Mazariegos GV et al. Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients. 2001 Paediatr Drugs pmid:11688597
Oz HS et al. Provocative effects of the immunosuppressants rapamycin, tacrolimus, and dexamethasone on pneumonitis in contrast to the anti- pneumonitis effects of mycophenolate mofetil. 2001 Transplantation pmid:11685124
Ovuworie CA et al. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. 2001 Transplantation pmid:11685108
Geba GP et al. Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity. 2001 Immunology pmid:11683964
Baan CC et al. Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression. 2001 Clin Transplant pmid:11683823
Barri YM et al. Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy. 2001 Clin Transplant pmid:11683817
Dietemann J et al. Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus. 2001 Nephrol. Dial. Transplant. pmid:11682676
Suehiro E et al. The immunophilin ligand FK506 attenuates the axonal damage associated with rapid rewarming following posttraumatic hypothermia. 2001 Exp. Neurol. pmid:11681852
Onoe H et al. [Interaction of immunophilin FKBP and intracellular Ca2+ release channels]. 2001 Fukuoka Igaku Zasshi pmid:11681278
Deters M et al. Comparative study analyzing effects of sirolimus-cyclosporin and sirolimus-tacrolimus combinations on bile flow in the rat. 2001 Dig. Dis. Sci. pmid:11680585
Sakuma Y et al. High-dose tacrolimus and lengthy survival of the combined rat pancreas/spleen graft in a high-responder combination. 2001 Transpl. Immunol. pmid:11680570
Arii T et al. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia. 2001 Neurol. Res. pmid:11680517
Chisholm MA et al. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. 2001 Clin Transplant pmid:11678959
Kimikawa M et al. Effective oral administration of tacrolimus in renal transplant recipients. 2001 Clin Transplant pmid:11678958
Mimura T et al. [Treatment of steroid-resistant polymyositis and dermatomyositis]. 2001 Nippon Rinsho pmid:11676154
Carreras CW et al. An FKBP12 binding assay based upon biotinylated FKBP12. 2001 Anal. Biochem. pmid:11673895
Fernández-Miranda C et al. Determinants of increased plasma homocysteine in 221 stable liver transplant patients. 2001 Clin. Chem. pmid:11673376
Wang M et al. Inhibition of nitric oxide synthase induces intestinal mucosal damage and increases mortality in rats treated by FK506. 2001 Exp. Toxicol. Pathol. pmid:11665854
Bornhövd E et al. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases. 2001 J. Am. Acad. Dermatol. pmid:11606925
Serrano AL et al. Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibers but not muscle growth. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11606756
Dello Strologo L et al. Renal hemodynamic effect of tacrolimus in renal transplanted children. 2001 Pediatr. Nephrol. pmid:11605779
Hardinger KL et al. Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era. 2001 Surgery pmid:11602906
Bultynck G et al. The conserved sites for the FK506-binding proteins in ryanodine receptors and inositol 1,4,5-trisphosphate receptors are structurally and functionally different. 2001 J. Biol. Chem. pmid:11598113
Christ B et al. Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation. 2001 Urology pmid:11597545
Dipchand AI et al. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil. 2001 J. Heart Lung Transplant. pmid:11595558
Naka Y et al. Effects of dexamethasone and FK506 on Helicobacter pylori-induced gastritis and bacterial viability in Mongolian gerbils. 2001 Jan-Dec J. Physiol. Paris pmid:11595473
Morissette P et al. In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil. 2001 Ther Drug Monit pmid:11591897
Sezen SF et al. Immunophilin ligand FK506 is neuroprotective for penile innervation. 2001 Nat. Med. pmid:11590407
Chau TN et al. Histological patterns of rejection using oral microemulsified cyclosporine and tacrolimus (FK506) as monotherapy induction after orthotopic liver transplantation. 2001 Liver pmid:11589769
Patel S et al. Prevalence and causes of low bone density and fractures in kidney transplant patients. 2001 J. Bone Miner. Res. pmid:11585351
Koomans HA and Ligtenberg G Mechanisms and consequences of arterial hypertension after renal transplantation. 2001 Transplantation pmid:11585243
First MR Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population. 2001 Transplantation pmid:11585240
Pescovitz MD and Govani M Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients. 2001 Am. J. Kidney Dis. pmid:11583940
Hricik DE Safety and efficacy of TOR inhibitors and other immunosuppressive regimens in African-American renal transplant recipients. 2001 Am. J. Kidney Dis. pmid:11583939
Ichimaru N et al. Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus. 2001 Atherosclerosis pmid:11583721
Assmann T et al. Topical tacrolimus for the treatment of inflammatory skin diseases. 2001 Expert Opin Pharmacother pmid:11583067
Simpson D New developments in the prophylaxis and treatment of graft versus host disease. 2001 Expert Opin Pharmacother pmid:11583062
Sloper CM et al. Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. 2001 Ophthalmology pmid:11581059
Jain A et al. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. 2001 Transplantation pmid:11579306
Savoldo B et al. Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients. 2001 Transplantation pmid:11579304
Selzner N et al. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. 2001 Transplantation pmid:11579301
Staatz CE et al. Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants. 2001 Transplantation pmid:11579300
Mourad G et al. Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. 2001 Transplantation pmid:11579299
Al-Uzri A et al. Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). 2001 Transplantation pmid:11579294
Lawrence MC et al. Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells. 2001 Mol. Endocrinol. pmid:11579208
Oettinger-Barak O et al. Periodontal changes in liver cirrhosis and post-transplantation patients. I: clinical findings. 2001 J. Periodontol. pmid:11577956
Thervet E [Minimization of immunosuppression]. 2001 Presse Med pmid:11577589
Bayle F [Focus on Islets of Langerhans transplantation]. 2001 Presse Med pmid:11577579